Beyond Air (NASDAQ:XAIR) CFO Daniel Moorhead Acquires 4,340 Shares

Beyond Air, Inc. (NASDAQ:XAIR) CFO Daniel Moorhead bought 4,340 shares of Beyond Air stock in a transaction dated Wednesday, July 29th. The shares were bought at an average cost of $5.76 per share, for a total transaction of $24,998.40. Following the completion of the transaction, the chief financial officer owned 4,340 shares of the company’s stock, valued at approximately $24,998.40. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Beyond Air Stock Down 2.6%

Shares of NASDAQ XAIR opened at $5.28 on Friday. The company has a debt-to-equity ratio of 3.48, a quick ratio of 3.59 and a current ratio of 3.80. The firm has a market capitalization of $3.80 million, a price-to-earnings ratio of -0.06 and a beta of 0.22. The stock has a 50 day moving average price of $7.69 and a 200 day moving average price of $14.21. Beyond Air, Inc. has a 52-week low of $5.02 and a 52-week high of $95.60.

Beyond Air (NASDAQ:XAIR) last announced its quarterly earnings data on Friday, June 26th. The company reported ($15.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($11.33) by ($4.07). The firm had revenue of $1.91 million during the quarter, compared to the consensus estimate of $2.30 million. Beyond Air had a negative return on equity of 350.00% and a negative net margin of 432.99%.

Institutional Trading of Beyond Air

A number of hedge funds have recently bought and sold shares of the stock. Osaic Holdings Inc. boosted its position in Beyond Air by 26.4% during the 2nd quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock valued at $29,000 after acquiring an additional 34,000 shares in the last quarter. Virtu Financial LLC bought a new position in shares of Beyond Air in the 3rd quarter worth $48,000. Geode Capital Management LLC lifted its stake in shares of Beyond Air by 57.5% during the 4th quarter. Geode Capital Management LLC now owns 67,678 shares of the company’s stock worth $49,000 after purchasing an additional 24,695 shares during the last quarter. Finally, Alyeska Investment Group L.P. purchased a new stake in shares of Beyond Air during the 3rd quarter worth $1,753,000. Hedge funds and other institutional investors own 31.50% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Beyond Air in a research note on Tuesday, July 21st. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $200.00.

About Beyond Air

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.